Sydney: Researchers are close to finding a shot that protects against many strains of meningococcal B, the most prevalent cause of a rare but serious infection affecting brain and spinal cord membranes.The disease can become fatal or cause great harm if you are not treated right away. Symptoms are red spots, a rundown feeling, sudden high fever, severe headache, neck stiffness, nausea or vomiting, discomfort in bright lights, drowsiness or difficulty in awakening, joint pain, etc.The trials of the potential vaccine had found it to be safe and stimulating an effective immune response, the journal The Lancet Infectious Diseases reports."Meningococcal B can cause meningitis and blood poisoning and can progress very quickly with devastating effects," said Peter Richmond, from the University of Western Australia (UWA), who led the study.Children between the ages of one month and one year are most at risk from meningococcal with a second peak in adolescents, he added, according to an UWA statement.
Vitamin D deficiency `worsens lupus`
Biodiversity loss can trigger rising allergy levels